【24h】

Control of Adult Stem Cell Function in Bioengineered In Vitro Niches

机译:对体外耐核素生物工程中成体干细胞功能的控制

获取原文

摘要

Blood stem cells, also termed hematopoietic stem cells (HSC), are used clinically to treat numerous blood cancers. However, due to the low numbers of HSCs that can be isolated from the bone marrow of donors, broad application of this treatment is severely hindered. A robust method is needed that enables in vitro propagation and expansion of HSCs. In addition, as soon as HSCs are removed from their bone marrow niches and put in culture, they begin to differentiate and lose their multipotency. Therefore, a different experimental approach is required to control HSC function in vitro. We have developed a novel microfabrication process to generate synthetic hydrogel substrates comprised of arrays of microwells that can be locally functionalized with desired stem cell regulatory proteins in simplified 'artificial niches'. Time-lapse microscopy of single cells in conjunction with image analysis was employed to quantify changes in the proliferation kinetics of individual HSCs in response to specific niche proteins. In combination with subsequent in vivo transplantation assays, we identified proteins that maintain stem cell multipotency in vitro by controlling self-renewal divisions.
机译:血液干细胞,也称为造血干细胞(HSC),临床上使用临床治疗无数血液癌症。然而,由于能够从供体的骨髓中分离的HSC的少量,因此严重阻碍了这种治疗的广泛应用。需要一种鲁棒的方法,使得能够体外传播和扩展HSC。此外,一旦HSC从他们的骨髓利基移除并养成文化,他们就开始区分并失去了多种。因此,在体外控制HSC功能需要不同的实验方法。我们开发了一种新型微制造方法,用于产生由微孔阵列组成的合成水凝胶基材,其可以在简化的“人造效力”中与所需的干细胞调节蛋白局部官能化。使用与图像分析结合的单细胞的延时显微镜,以量化单个HSC的增殖动力学的变化,以响应特定的Niche蛋白。结合在体内移植测定中的随后,我们通过控制自我更新分裂来确定维持干细胞多能力的蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号